As lead candidate mipletamig continues to outperform efficacy and safety benchmarks in AML trials, APVO711 exemplifies emerging innovation from Aptevo's proprietary ADAPTIR® platformIn preclinical ...

Scientists have developed an A.I. tool that they say can help assess a patient’s health — and potentially guide their medical ...

Ever since Wordle exploded in popularity some years ago, comparable word, geography and maths games have emerged to play on a daily basis. In the geography category, Globle is one that has been ...

A key enzyme and its molecular pathway are critical to keeping certain immune cells active and away from "exhaustion," ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from ...

Mass General Brigham researchers created an AI tool that uses a simple face photograph to predict how well a patient may fare ...

A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection in mice.

Research Triangle Park, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- <li /> Three oral and 12 poster presentations demonstrate breadth and progress o ...